Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Ketolides Market Growth Performance Trended Historically, And What Lies Ahead?
The market volume of ketolides has seen a consistent increase over recent years. Its size is predicted to swell from $3.22 billion in 2024 to $3.32 billion in 2025 with a compound annual growth rate (CAGR) of 3.1%. This steady growth in the past years is due to factors like rising incidence of infectious diseases, increased use of antibiotics, need for effective and easy-to-administer treatments for infectious conditions, and government interventions.
Predictions indicate a consistent expansion in the ketolides market in the upcoming years, with it expected to reach a value of $3.99 billion in 2029, growing at a compound annual growth rate of 4.7%. The projected growth during this period is largely due to increased research and development initiatives for ketolides, a rise in screening initiatives for infectious diseases, growing healthcare expenditure, and heightened awareness regarding antimicrobial stewardship. The major trends expected to surface during the forecast period include the creation of innovative treatments for infectious diseases, the development of targeted therapies, improvements in the diagnosis and treatment techniques of infectious diseases, and the creation of new ketolide formulations.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12918&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Ketolides Market?
The growth of the ketolides market is expected to be driven by the rising prevalence of infectious diseases. Infectious diseases, which can be caused by bacteria, viruses, fungi, or parasites, can spread between individuals and lead to various symptoms and health problems. Tuberculosis is an example of an infectious disease. Ketolides, often employed in treating these illnesses, display high intracellular activity, making them potentially useful in the treatment of tuberculosis. For instance, UK’s GOV.UK reported in February 2024 that tuberculosis cases in England saw an increase of 10.7% in 2023, jumping from 4,380 cases in 2022 to 4,850. Given this, the expanding incidence of infectious diseases is propelling the growth of the ketogenic market.
Which Key Market Segments Comprise the Ketolides Market and Drive Its Revenue Growth?
The ketolides market covered in this report is segmented –
1) By Drug Type: Telithromycin, Cethromycin, Solithromycin
2) By Indication: Bronchitis, Pneumonia, Sinusitis, Tonsillitis Or Pharyngitis
3) By Microorganism: Streptococcus Pneumoniae, Haemophilus Influenzae, Moraxella Catarrhalis, Chlamydophila Pneumoniae, Mycoplasma Pneumoniae
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12918&type=smp
Which Areas Are Leading Regions in the Ketolides Market Expansion Across the Globe?
North America was the largest region in the ketolides market in 2024. The regions covered in ketolides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Key Market Trends in theKetolides Market Over the Coming Years?
Key players in the ketolides market are concentrating their efforts on the development of novel drugs and treatments as a means to maintain competitiveness and secure their market standing. For instance, in June 2023, US-based biotechnology research firm, AliquantumRx Inc., was granted approval for its patent ‘salts and polymorphs of cethromycin for the treatment of bacterial and protozoan disease’ by the United States Patent and Trademark Office (USPTO), an arm of the Department of Commerce. Cethromycin, a ketolide antibiotic, is known to effectively treat a broad range of bacteria and protozoa induced diseases, including malaria, babesiosis, toxoplasmosis, diarrhea among others. This newly awarded patent is set to broaden the company’s reach, reduce the commercialization risks of cethromycin, and permits its use for diseases beyond malaria.
View the full report here:
https://www.thebusinessresearchcompany.com/report/ketolides-global-market-report
How Is the Ketolides Market Conceptually Defined?
Ketolides are a class of antibiotics that belong to the macrolide group derived from erythromycin, a 14-membered macrolide, by substituting the cladinose sugar with a keto-group and attaching a cyclic carbamate group in the lactone ring. They prevent protein synthesis and prevent bacteria from producing vital proteins needed for maintenance and survival.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12918
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model